De Clerck Eline Elodie Barbara, Bravetti Giorgio Enrico, Kropp Martina, Massa Horace, Pajic Bojan, Thumann Gabriele, Guber Ivo
Division of Ophthalmology, Department of Clinical Neurosciences, Geneva University Hospitals, 1205 Geneva, Switzerland.
Experimental Ophthalmology, University of Geneva, 1205 Geneva, Switzerland.
J Clin Med. 2023 Mar 20;12(6):2402. doi: 10.3390/jcm12062402.
(1) Background: Mid-stromal isolated Bowman layer transplantation aims to reduce and stabilize corneal ectasia in patients with advanced, progressive keratoconus. The purpose of this review is to evaluate the effectiveness and safety of this new surgical technique. (2) Methods: Following the PRISMA statement and checklist, we searched Medline, the Cochrane Controlled Trials Register, and Embase and used a broad systematic search strategy according to the Cochrane Collaboration. (3) Results: Eight studies with a total number of 120 eyes of 106 patients met our inclusion criteria. One month after Bowman layer transplantation, patients with keratoconus showed a significant decrease in the measured simulated keratometry (-4.74 D [95% CI -6.79 to -2.69]) and the maximum keratometry (-7.41 D [95% CI -9.64 to -5.19]), which remained significant one year postoperatively (-2.91 D [95% CI -5.29 to -0.53] and -5.80 D [-8.49 to -3.12]). Intra- and postoperative complications were observed in 3% and 9% of the patients, respectively. An estimated success rate of 75% to 85% was achieved by experienced surgeons at 5 to 8 years postoperatively. (4) Conclusions: Bowman layer transplantation may be an effective and safe treatment option in patients with advanced, progressive keratoconus. Additional multicenter prospective interventional studies are needed to confirm these preliminary findings.
(1)背景:基质中层孤立性Bowman层移植旨在减轻并稳定晚期进行性圆锥角膜患者的角膜扩张。本综述的目的是评估这种新手术技术的有效性和安全性。(2)方法:遵循PRISMA声明和清单,我们检索了Medline、Cochrane对照试验注册库和Embase,并根据Cochrane协作组织采用了广泛的系统检索策略。(3)结果:八项研究共纳入106例患者的120只眼,符合我们的纳入标准。Bowman层移植术后1个月,圆锥角膜患者的测量模拟角膜曲率(-4.74 D [95%置信区间-6.79至-2.69])和最大角膜曲率(-7.41 D [95%置信区间-9.64至-5.19])显著降低,术后1年仍保持显著(-2.91 D [95%置信区间-5.29至-0.53]和-5.80 D [-8.49至-3.12])。分别有3%和9%的患者在术中及术后出现并发症。经验丰富的外科医生在术后5至8年实现的估计成功率为75%至85%。(4)结论:Bowman层移植对于晚期进行性圆锥角膜患者可能是一种有效且安全的治疗选择。需要更多的多中心前瞻性干预研究来证实这些初步发现。